Find your next paid study

Abramson Cancer Center at Penn MedicineNCT05733715

~$500 – $7,500

Actual pay is set by the research site.

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Empagliflozin Among Patients Initiating Hemodialysis for the Treatment of End-Stage Kidney Disease

A 12-week, phase II, randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability, and preliminary efficacy of empaglifl…

End Stage Renal Disease

NYU Langone HealthNCT05786443

~$75 – $3,000

Actual pay is set by the research site.

High Grade GliomaCNS Tumor

PHASE 2 Study of Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors (GLOBOTRK)

This clinical trial tests how well entrectinib works to treat patients less than 3 years of age with NTRK 1/2/3 or ROS1 fused, high grade glioma or other centr…

St. Jude Children's Research HospitalNCT06528691

Actual pay is set by the research site.

Non Small Cell Lung Cancer

DISCERN: Dual Immune Strategy Versus Single Checkpoint Inhibition Efficacy Response in PDL-1 Negative Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study, known as DISCERN, is to compare two different treatments for a type of lung cancer called non-small cell lung cancer (NSCLC) that do…

University of Alabama at BirminghamNCT06364917

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of Rondecabtagene Autoleucel, a CD19/CD20 Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy in Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of rondecabtagene autoleucel (ronde-cel) also known as LYL314, a dual-ta…

Relapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin LymphomaNon-Hodgkin Lymphoma+1 more

Lyell Immunopharma, Inc.NCT05826535

~$150 – $4,200

Actual pay is set by the research site.

Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia

Low social motivation is a significant symptom of schizophrenia and is a major cause of disability and suffering for many patients struggling with the illness.…

Schizophrenia

University of California, Los AngelesNCT05778591

Actual pay is set by the research site.

Phase 1

Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities

Phase 1 and 2 trial to study the safety, pharmacokinetics, and efficacy of TAS0953/HM06 in patients with advanced solid tumors with RET gene abnormalities. Pha…

RET-altered Non Small Cell Lung CancerRET-altered Solid Tumors

Taiho Pharmaceutical Co., Ltd.NCT04683250

~$150 – $4,200

Actual pay is set by the research site.

Non-interventional Cohort Study of Patients Treated With Liso-cel (Lisocabtagene Maraleucel) for Relapsed/Refractory Follicular Lymphoma in the Postmarketing Setting

The purpose of this study is to characterise the long-term safety of lisocabtagene maraleucel, focusing on patients treated in the approved follicular lymphoma…

Follicular Lymphoma

Pay not disclosed — ask the coordinator

Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyNCT06794268

Combined Hepatocellular and Cholangiocarcinoma

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab (STRIDE) Plus Gemcitabine and Cisplatin (GEMCIS) in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma (cHCC-CCA)

This is a single arm phase 2 study of Single Tremelimumab with Regular Interval Durvalumab (STRIDE) plus Gemcitabine and Cisplatin (GEMCIS) in locally advanced…

~$75 – $3,000

Actual pay is set by the research site.

Mehmet AkceNCT06855225

A Randomized Phase II Trial of Cemiplimab With or Without Fianlimab in Patients With Detectable Minimal-residual Disease After Definitive Treatment for Human Papillomavirus Positive HPV(+) Head and Neck Cancer.

The goal of this clinical trial is to learn if the combination of cemiplimab and fianlimab can improve outcomes compared to cemiplimab alone in adults with Hum…

Head and Neck Cancer

University of ChicagoNCT07179315

Actual pay is set by the research site.

Observational

Effect of "Online MedEd" Intern Boot Camp Training on First Year Residents' Well-being: A Pilot Randomized Controlled Trial

This single-center, parallel-group randomized controlled trial will evaluate whether a seven-week, web-based "Online MedEd Intern Boot Camp" (OME-IB) program r…

Burnout Among First Year Residents

New York City Health and Hospitals CorporationNCT06977243

~$10 – $750

Actual pay is set by the research site.

Understanding the Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy

The goal of this observational study is to learn more about the biology of cervical cancer in women who receive radiation therapy for this condition. The main …

Cervical Cancer